BRIEF-Transcode Therapeutics Inc - Enters Exclusive License Agreement With Unleash

Reuters03-03 21:12

BRIEF-Transcode <a href="https://laohu8.com/S/LENZ">Therapeutics</a> Inc - Enters Exclusive License Agreement With Unleash

March 3 (Reuters) - Transcode Therapeutics Inc RNAZ.O:

TRANSCODE THERAPEUTICS INC - ENTERS EXCLUSIVE LICENSE AGREEMENT WITH UNLEASH
TRANSCODE THERAPEUTICS INC - UNDER AGREEMENT, UNLEASH TO RECEIVE 1,136,364 SHARES OF TRANSCODE PREFERRED STOCK

Source text: ID:nPn6tQlTva

Further company coverage: RNAZ.O

((Reuters.Briefs@thomsonreuters.com;))

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2616328931?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-03 21:12","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2616328931","market":"nz","top_or_hot":-1,"title":"BRIEF-Transcode Therapeutics Inc - Enters Exclusive License Agreement With Unleash","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Transcode <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> Inc - Enters Exclusive License Agreement With Unleash</title></head><body><p><span>March 3 (Reuters)</span><span> - </span>Transcode Therapeutics Inc <span>RNAZ.O</span>:</p><ul><li><p>TRANSCODE THERAPEUTICS INC - ENTERS EXCLUSIVE LICENSE AGREEMENT WITH UNLEASH</p></li><li><p>TRANSCODE THERAPEUTICS INC - UNDER AGREEMENT, UNLEASH TO RECEIVE 1,136,364 SHARES OF TRANSCODE PREFERRED STOCK</p></li></ul><p>Source text: <span>ID:nPn6tQlTva</span></p><p>Further company coverage: <span>RNAZ.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Transcode Therapeutics Inc - Enters Exclusive License Agreement With Unleash</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Transcode Therapeutics Inc - Enters Exclusive License Agreement With Unleash\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2026-03-03 21:12</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Transcode <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> Inc - Enters Exclusive License Agreement With Unleash</title></head><body><p><span>March 3 (Reuters)</span><span> - </span>Transcode Therapeutics Inc <span>RNAZ.O</span>:</p><ul><li><p>TRANSCODE THERAPEUTICS INC - ENTERS EXCLUSIVE LICENSE AGREEMENT WITH UNLEASH</p></li><li><p>TRANSCODE THERAPEUTICS INC - UNDER AGREEMENT, UNLEASH TO RECEIVE 1,136,364 SHARES OF TRANSCODE PREFERRED STOCK</p></li></ul><p>Source text: <span>ID:nPn6tQlTva</span></p><p>Further company coverage: <span>RNAZ.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260303:nFWN3ZR198:1","article_id":"2616328931","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2616328931","pubTimestamp":1772543527,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Transcode Therapeutics Inc - Enters Exclusive License Agreement With UnleashMarch 3 (Reuters) - Transcode Therapeutics Inc RNAZ.O:TRANSCODE THERAPEUTICS INC - ENTERS EXCLUSIVE LICENSE AGREEMENT ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4139":"生物科技","BK4539":"次新股","RNAZ":"TransCode Therapeutics  Inc."},"translate_title":"简介-Transcode Therapeutics Inc-与Unleash签订独家许可协议","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"RNAZ":0.9},"content_text":"BRIEF-Transcode Therapeutics Inc - Enters Exclusive License Agreement With UnleashMarch 3 (Reuters) - Transcode Therapeutics Inc RNAZ.O:TRANSCODE THERAPEUTICS INC - ENTERS EXCLUSIVE LICENSE AGREEMENT WITH UNLEASHTRANSCODE THERAPEUTICS INC - UNDER AGREEMENT, UNLEASH TO RECEIVE 1,136,364 SHARES OF TRANSCODE PREFERRED STOCKSource text: ID:nPn6tQlTvaFurther company coverage: RNAZ.O ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":true,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2616328931","isCrawlerRequest":true}